文献速递重症综合管理与镇静镇痛儿科与产科急症消化、代谢与肾脏急症

婴儿心胸外科术后碱性磷酸酶活性与内毒素血症

Alkaline Phosphatase Activity and Endotoxemia After Infant Cardiothoracic Surgery.
PubMed 文献 · Shock · 2019-01-01
一句话结论婴儿体外循环后内毒素血症常见,内源性碱性磷酸酶活性与内毒素活性呈负相关,体外加入人肝碱性磷酸酶可降低全血内毒素活性。

这项前瞻性队列研究纳入62例≤120日龄接受体外循环的婴儿,在术前、复温期和心脏ICU入住24小时后测定血清碱性磷酸酶活性和内毒素活性测定值。结果显示体外循环期间碱性磷酸酶活性平均下降94.8 U/L(P<0.0001),内毒素活性从术前中位数0.41升至复温期0.52(P<0.05)并持续升高至24小时。术前碱性磷酸酶活性低的婴儿术前和复温期内毒素活性更高(分别为0.47 vs 0.36,P<0.05;0.59 vs 0.43,P<0.01)。在22例样本中体外加入1,600 U/L人肝碱性磷酸酶使术前内毒素活性降低29%(P<0.001)、复温期内毒素活性降低51%(P<0.0001)。

要点

  • 婴儿体外循环期间血清碱性磷酸酶活性平均下降94.8 U/L(P<0.0001),复温期内毒素活性中位数从术前0.41升至0.52(P<0.05)并持续升高至术后24小时。
  • 术前碱性磷酸酶活性低的婴儿术前内毒素活性为0.47 vs 0.36(P<0.05)、复温期为0.59 vs 0.43(P<0.01),24小时差异未达统计学显著(0.52 vs 0.45,P=0.12)。
  • 在22例婴儿的全血样本中体外加入1,600 U/L人肝碱性磷酸酶,术前内毒素活性降低29%(P<0.001)、复温期内毒素活性降低51%(P<0.0001)。
  • 作者认为未来研究应评估碱性磷酸酶作为治疗手段以减少婴儿体外循环后内毒素血症的有害影响。

适用人群与场景

  • ≤120日龄接受体外循环的婴儿,共62例,来自前瞻性队列研究。

研究设计与关键结果

  • 研究类型为前瞻性队列研究,样本量62例,人群为≤120日龄接受体外循环的婴儿。
  • 体外循环期间血清碱性磷酸酶活性平均下降94.8 U/L(P<0.0001)。
  • 内毒素活性中位数术前为0.41,复温期升至0.52(P<0.05),心脏ICU入住24小时后仍稳定升高。
  • 术前碱性磷酸酶活性低的婴儿术前内毒素活性为0.47 vs 0.36(P<0.05),复温期为0.59 vs 0.43(P<0.01),24小时内毒素活性为0.52 vs 0.45(P=0.12,未达统计学显著)。
  • 复温期碱性磷酸酶活性低的婴儿内毒素活性差异相似但未达统计学显著。
  • 在22例受试者的术前和复温期全血样本中体外加入1,600 U/L人肝碱性磷酸酶,术前内毒素活性降低29%(P<0.001),复温期内毒素活性降低51%(P<0.0001)。

证据类型、等级与局限

  • 证据类型为前瞻性队列研究,原文未报告推荐等级或证据分级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为未来研究应评估碱性磷酸酶作为治疗手段以减少婴儿体外循环后内毒素血症的有害影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Infant cardiopulmonary bypass (CPB) increases intestinal permeability leading to endotoxemia. Alkaline phosphatase (AP) reduces endotoxin toxicity in vitro but its effects on endotoxemia in human disease are poorly understood. We assessed the association between serum AP activity and endotoxemia in infants undergoing CPB and determined the effect of ex vivo addition of AP on endotoxemia.

METHODS: Prospective cohort study of 62 infants ≤120 days of age undergoing CPB. AP activity and Endotoxin Activity Assay (EAA) were measured pre-operatively, during rewarming, and 24 h after cardiac intensive care unit admission. In 22 subjects, EAA was measured in pre-operative and rewarming whole blood samples with/without addition of 1,600 U/L of human liver AP.

RESULTS: AP activity decreased during CPB (mean decrease 94.8U/L; P < 0.0001). Median EAA was 0.41 pre-operation, rose to 0.52 (P < 0.05) during rewarming, and remained stably elevated at 24 h. Subjects with low pre-operative AP activity had significantly higher pre-operative (0.47 vs. 0.36; P < 0.05) and rewarming (0.59 vs. 0.43; P < 0.01) EAA with a trend toward higher EAA at 24 h (0.52 vs. 0.45; P = 0.12). Subjects with low rewarming AP activity showed similar differences that did not reach statistical significance. Ex vivo addition of human liver AP decreased pre-operative EAA by 29% (P < 0.001) and rewarming EAA by 51% (P < 0.0001).

CONCLUSION: Endotoxemia is common in infants undergoing CPB. Native AP activity and endotoxemia are inversely related and ex vivo addition of exogenous AP reduces whole blood EAA. Future research should evaluate AP as a therapy to reduce the harmful effects of endotoxemia following infant CPB.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Davidson JA, Urban TT, Tong S, et al. Alkaline Phosphatase Activity and Endotoxemia After Infant Cardiothoracic Surgery. Shock. 2019. PMID: 29664834. doi:10.1097/SHK.0000000000001162

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。